On Oct. 28, HHS announced an interim final rule with request for comments. The rule, issued by HHS, the U.S. Departments of Labor and the Treasury and the IRS, calls for all health care payers to offer a COVID-19 vaccine, when it becomes available via FDA authorization, as a Medicare preventive vaccine without cost-sharing.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.
Quick, Current, Complete - www.findacode.com